Literature DB >> 16630161

The alpha4bbeta7-integrin is dynamically expressed on murine eosinophils and involved in eosinophil trafficking to the intestine.

E B Brandt1, N Zimmermann, E E Muntel, Y Yamada, S M Pope, A Mishra, S P Hogan, M E Rothenberg.   

Abstract

BACKGROUND: Of the numerous adhesion molecules expressed by eosinophils, the alpha4-integrin has been identified as critically involved in eosinophil trafficking in the lung. Most studies have focused on the role of the alpha4beta1-adhesion complex, but eosinophils also express the alpha4beta7-integrin complex.
OBJECTIVE: To investigate the role of alpha4beta7, by assessing its membrane expression on eosinophils from different compartments using allergen-challenged mice and IL-4/IL-5 bi-transgenic mice. In addition, we aim to determine the impact of beta7-integrin deficiency on eosinophil recruitment to the lungs and intestine in specific experimental allergic models.
RESULTS: Evaluation of alpha4beta7 expression on bronchoalveolar lavage fluid (BALF) and lung tissue eosinophils revealed a down-regulation of this integrin as eosinophils migrate through the lungs. Indeed eosinophils isolated from the BALF and lung of allergic mice had low expression of the alpha4beta7-complex. While expression of the alpha4-chain remained unchanged, a significant decrease in beta7-surface expression was observed. Intestinal eosinophils, isolated from Peyer's patches, also displayed a down-regulation of the alpha4beta7-integrin, albeit only modest. In contrast, circulating eosinophils, isolated from the blood and spleen, expressed high levels of the alpha4beta7-integrin. However, eosinophil trafficking into the lungs of beta7-integrin-deficient mice was not significantly impaired in response to respiratory allergen challenges. In contrast, beta7-deficient mice had impaired eosinophil recruitment to the intestine.
CONCLUSION: Taken together, these results identify differential expression of the alpha4beta7-integrin on eosinophils and its critical role in regulating eosinophil responses in the intestine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16630161     DOI: 10.1111/j.1365-2222.2006.02456.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  24 in total

Review 1.  Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?

Authors:  Tim Raine
Journal:  United European Gastroenterol J       Date:  2014-10       Impact factor: 4.623

2.  EDA-containing cellular fibronectin induces fibroblast differentiation through binding to alpha4beta7 integrin receptor and MAPK/Erk 1/2-dependent signaling.

Authors:  Martin Kohan; Andres F Muro; Eric S White; Neville Berkman
Journal:  FASEB J       Date:  2010-07-19       Impact factor: 5.191

Review 3.  Biological therapies for eosinophilic gastrointestinal diseases.

Authors:  Joshua B Wechsler; Ikuo Hirano
Journal:  J Allergy Clin Immunol       Date:  2018-05-31       Impact factor: 10.793

Review 4.  Shaping eosinophil identity in the tissue contexts of development, homeostasis, and disease.

Authors:  Hiam Abdala-Valencia; Mackenzie E Coden; Sergio E Chiarella; Elizabeth A Jacobsen; Bruce S Bochner; James J Lee; Sergejs Berdnikovs
Journal:  J Leukoc Biol       Date:  2018-04-14       Impact factor: 4.962

Review 5.  Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders.

Authors:  Steven J Ackerman; Bruce S Bochner
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

Review 6.  Heterogeneity across the murine small and large intestine.

Authors:  Rowann Bowcutt; Ruth Forman; Maria Glymenaki; Simon Richard Carding; Kathryn Jane Else; Sheena Margaret Cruickshank
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

7.  Resolution of Refractory Eosinophilic Esophagitis with the Leukocyte-Trafficking Inhibitor Natalizumab.

Authors:  Ian L P Beales
Journal:  Dig Dis Sci       Date:  2019-06-12       Impact factor: 3.199

Review 8.  What targeting eosinophils has taught us about their role in diseases.

Authors:  Bruce S Bochner; Gerald J Gleich
Journal:  J Allergy Clin Immunol       Date:  2010-07       Impact factor: 10.793

9.  The extracellular matrix protein mindin regulates trafficking of murine eosinophils into the airspace.

Authors:  Zhuowei Li; Stavros Garantziotis; Wei Jia; Erin N Potts; Sikander Lalani; Zhi Liu; You-Wen He; W Michael Foster; John W Hollingsworth
Journal:  J Leukoc Biol       Date:  2008-09-25       Impact factor: 4.962

Review 10.  Chemotactic factors associated with eosinophilic gastrointestinal diseases.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.